Hansoh Pharmaceutical Group Company Limited (3692.HK) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in China, listed on HKSE. Market cap 191.22B HKD. 52-week range 28.06 to 44.22 HKD. Trailing P/E 25.2. Data as of 2026-10-09.
Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, ...